RBCC Elects Kimberly Palmer as New CEO [Health & Beauty Close - Up]
(Health & Beauty Close - Up Via Acquire Media NewsEdge) Growing biotechnology company Rainbow Coral Corp. announced that the company has appointed Kimberly Palmer as new president and CEO.
A registered nurse with extensive healthcare experience, RBCC said that Palmer will be tasked with implementing its developing business strategy in the field of regenerative medicine. For the past eight years, she has served as a business consultant to private surgeons, providing administrative and clinical support for a variety of medical practices. She also brings experience with surgical pre- and post-operative patient care to RBCC.
At RBCC, Palmer will spearhead the marketing and development of new breakthroughs in regenerative and precision medicine. In recent years, major discoveries in the usage of adult stem cells and biologics have led to promising advances in the treatment of illnesses from chronic back pain to leukemia and even AIDS.
With new, patentable regenerative therapies being developed all over the U.S., RBCC is reaching out to industry leaders regarding development partnerships expected to significantly boost the company's bottom line.
"We are entering an exciting new chapter in the history of medicine, and RBCC is right on the cutting-edge of this new field of regenerative therapy," Palmer said. "I look forward to leading this growing company into a very bright future for our partners and investors."
By acquiring or partnering with up-and-coming regenerative therapy companies, RBCC said that it plans to be well-positioned to capitalize on the big growth in store for the industry. The company invests in technology developed to compete in the biotechnology industry alongside Amgen, Dendreon Corp., Smith & Nephew and Pharmaceutical Product Development.
((Comments on this story may be sent to firstname.lastname@example.org))
(c) 2013 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To Technology News's Homepage ]